Summary
The serum levels of copper and zinc were estimated by atomic absorption spectrometry in 7 women with silastic implants releasing norethisterone acetate 140 μg/day. No appreciable change was observed in the circulating concentrations of either of the trace metals after use of the implant for a period of up to 12 months. There was also no change in the serum copper and zinc concentrations during the proliferative and secretory phases of the normal menstrual cycles in 15 women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Underwood EJ. Trace elements in human and animal nutrition. 4th ed. New York Acad Press 1971; 208: 1,8,24
Henkin RI. Trace metals in endocrinology. Med Clin North Am 1976; 60: 779–95
Margen S, King JC. Effect of oral contraceptive agents on metabolism of some trace elements. Am J Clin Nutr 1975; 28: 392–402
Funkes CG, Chvapil M, Carrel RW, et al. Effect of a long acting contraceptive drug, norethindrone enanthate, on serum zinc and copper in human volunteers. Contraception 1976; 14: 291–6
Schenker JG, Hellerstein S, Jungreis E, et al. Serum copper and zinc levels in patients taking oral contraceptives. Fertil Steril 1971; 22: 229–31
Prasad AS, Oberleas D, Lei KY, et al. Effects of oral contraceptive agents on nutrients: 1. Minerals. Am J Clin Nutr 1975; 28: 377–84
Thorp VJ. Effects of oral contraceptive agents on vitamin and mineral requirements. J Am Diet Assoc 1980; 6: 581–4
Briggs M, Austin J, Stainford M. Oral contraceptives and copper metabolism. Nature 1970; 81: 225
Briggs MH, Briggs M. Contraception and serum patients. BMJ 1970; 3: 521–9
Daunter B, Elsteiner M. Serum levels of copper ceruloplasmin and ceruloplasmin oxidase activity in women using copper containing intrauterine devices and in women taking combined oral contraceptives. J Obstet Gynecol Brit Commonwealth 1973; 80: 644–7
Ismail AAA, Toppozada M, Zahran M, et al. Serum nickel, copper and zinc in Norplant users. Contraception 1992; 15: 561–72
Takkar D, Anandlaxmi PN, Chandra VL, et al. Long term contraception by a single silastic implant D containing norethindrone acetate in women. A clinical evaluation. Contraception 1978; 17: 311–51
Sunderman FW, Roszel ND. Measurements of copper in biological materials by atomic absorption spectrometry. Am J Clin Pathol 1967; 18: 286–94
Haagenfeldt R, Plantin LD, Dicsfalusy E. Trace elements in human endometrium. Acta Endocrinol 1973; 72: 115–26
Rubinfeld Y, Maer Y, Simon D, et al. A progressive rise in serum copper levels in women taking oral contraceptives: A potential hazard. Fertil Steril 1979; 32: 599–601
Powell-Beard L, Lei KY, Schenker L. Effect of long term oral contraceptives therapy before pregnancy on maternal and fetal zinc and copper status. Obstet Gynecol 1987; 69: 26–32
Hillier SG, Jha P, Griffith GK, et al. Long term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. Contraception 1977; 15: 473–88
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jha, P., Takkar, D. & Farooq, A. Effects of Norethisterone Acetate Released from a Silastic Implant on Serum Copper and Zinc Levels in Women. Drug Invest 8, 383–386 (1994). https://doi.org/10.1007/BF03257454
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257454